Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed rule

Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Aug. 3, 2026. Document 2026-15624. Updated Nov. 7, 2026.

What it does

The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA), as list I chemicals under the CSA. The current listing of 3,4- MDP-2-P methyl glycidic acid includes its salts, optical and geometric isomers, and salts of isomers. DEA proposes the new listing to read as follows: 3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid) and its esters, not listed elsewhere in the CSA, its optical and geometric isomers, its salts, salts of its optical and geometric isomers, salts of its esters, not listed elsewhere in the CSA, and any combination thereof, whenever the existence of such is possible.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What it would change

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 1310

What happens next and when

Comments must be submitted electronically or postmarked on or before September 2, 2026. Commenters should be aware that the electronic Federal Docket Management System will not accept any comments after 11:59 p.m. Eastern Time on the last day of the comment period.

The agency's dates, word for word.

Document number2026-15624
ActionNotice of proposed rulemaking.
AgenciesJustice Department; Drug Enforcement Administration
PublishedAug. 3, 2026
Comments closeSept. 2, 2026
DocketDEA-2026-1288

Source: the Federal Register (public domain). The document in the Federal Register